Literature DB >> 8988338

Interleukin-4 stimulates rheumatoid synovial fibroblasts to express matrix metalloproteinase-1 (tissue collagenase) and histamine H1 receptor mRNA.

M Zenmyo1, K Hiraoka, T Sasaguri, S Komiya, A Inoue, M Morimatsu, Y Sasaguri.   

Abstract

In the present study, we investigated the effect of interleukin-4 (IL-4) on metalloproteinase 1 (MMP-1/tissue collagenase) production in human rheumatoid synovial fibroblasts. Northern blot analysis revealed that addition of IL-4 with or without histamine stimulated the cells to increase the amount of proMMP-1 mRNA, and the IL-4 with histamine addition resulted in a 3.3-fold increase compared with histamine only. Furthermore, IL-4 itself stimulated the expression of histamine H1 receptor mRNA. These results suggest that IL-4 may play an important role in joint destruction in RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8988338     DOI: 10.1080/15216549600201903

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  4 in total

1.  Interleukin-4 up-regulates histamine H1 receptors by activation of H1 receptor gene transcription.

Authors:  Shuhei Horio; Katsumi Fujimoto; Hiroyuki Mizuguchi; Hiroyuki Fukui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-30       Impact factor: 3.000

2.  Structure of the human histamine H1 receptor gene.

Authors:  M D De Backer; I Loonen; P Verhasselt; J M Neefs; W H Luyten
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

3.  Effect of histamine on the production of matrix metalloproteinases-1, -3, -8 and -13, and TNFalpha and PGE(2) by human articular chondrocytes and synovial fibroblasts in vitro: a comparative study.

Authors:  Lynne C Tetlow; David E Woolley
Journal:  Virchows Arch       Date:  2004-09-17       Impact factor: 4.064

4.  Localization and upregulation of the nasal histamine H1 receptor in perennial allergic rhinitis.

Authors:  Hideaki Shirasaki; Etsuko Kanaizumi; Nobuhiko Seki; Tetsuo Himi
Journal:  Mediators Inflamm       Date:  2012-10-23       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.